The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 2.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (21 analysts) rates it buy, with a mean price target of $255.
Capital One
COF · a US exchange · USD · Market cap $131.3B · 77,100 employees
Capital One Financial Corporation operates as the financial services holding company for the Capital One, National Association, which engages in the provision of various financial products and services in the United Stat…
FAIL · Does not pass the screenAt the last full screen
2026-09-08
Screened 2026-09-08 · the tape above runs as of 13:00 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its markdown label.
Capital One holds its Markdown at $213.96. The statistical read favours the sellers, held for 41 days.
| Phase | Markdown · caution |
| Quantitative state | The statistical read favours the sellers, held for 41 days |
| Price at the screen | $213.96 |
| Valuation | 11.78 trailing · 8.91 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 1.02 |
Five Screens, Shown in Full
Does not pass. Business activity screen
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Excluded | Core business clean | Business activity: Financials sector | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
What the Numbers Say It Is WorthThe Fair Value Range
Our framework reads AVOID: it trades at roughly a 40% discount to our $300.00 fair value, narrow competitive moat, 1,111.00% revenue growth.
Fair value range in USD, drawn from the 2026-09-08 screen. The gold marker is the market price at the same screen. A 40.2% margin of safety to the base estimate.
Third-party analyst targets: 22 covering, consensus Buy. The average target sits +19% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-09-08 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsCapital One's Ethics Miss Outweighs Financials
Every time a customer swipes their Capital One card or applies for a loan, they're dealing with a company that has a strong financial footing but a failing ethical scorecard. Capital One operates as a financial services holding company, with a robust revenue growth of 1111% and a healthy profit margin of 22%. Despite these impressive numbers, the company's business activities have led to it failing our ethical screen, which is a critical factor we consider.
Why it stands out, at first glance, is the significant margin of safety. With our fair value estimate at $300, there's a +41% upside from the current price of $212.48. Coupled with a forward P/E of 8.8x, which is quite attractive, and a respectable return on equity of 9%, the numbers might suggest a compelling investment. However, this is overshadowed by the ethical failings, which we cannot overlook.
Risk sits around failing the ethical screen, which is non-negotiable for our investment considerations. Despite the bullish financial metrics and the consensus buy rating from 22 analysts with a median target of $254, the ethical failing is a significant red flag. This is not just about numbers; it's about aligning investments with values. Analysis, not advice.
| Forward P/E | 8.9xcheap for a company growing this fast |
| Trailing P/E | 11.8xreasonably valued |
| EPS, trailing | 18.16 |
| EPS, forward | 24.01 |
| Revenue growth | +1,111.0%growing very fast |
| Profit margin | 21.9%healthy profit margins |
| Return on equity | 9.0%a modest return on shareholder capital |
| Dividend yield | 169.00% |
| Beta | 1.02moves a little more than the market |
| Short interest, float | 0.02% |
| 52-week range | 174.24 - 259.64 |
| Moat | NARROW |
| Market cap | $131.3B |
| Employees | 77,100 |
The risks · The main risks here are ordinary market swings and the chance our fair-value read proves too optimistic.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeCOF trades on a US exchange. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (21 analysts) rates it buy, with a mean price target of $255. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (21 analysts) rates it buy, with a mean price target of $255. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 15.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (21 analysts) rates it buy, with a mean price target of $255. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (21 analysts) rates it buy, with a mean price target of $255. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (21 analysts) rates it buy, with a mean price target of $255. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 10%. Our forward projection puts the odds of a 10% gain over the next month near 26%. The street (21 analysts) rates it buy, with a mean price target of $255. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- US Senate panel votes to advance Trump pick for consumer watchdog Reuters · 23h ago
- 1 Cash-Heavy Stock for Long-Term Investors and 2 We Ignore StockStory · 2d ago
- How To Make $3,500 in Free Checking Account Bonuses — Reddit Found a Way MoneyLion · 3d ago
- The Forgotten Generation Is Broke: 50% of All New Bankruptcies Are 40-59 Year Olds 24/7 Wall St. · 3d ago
- The high-end card changes that are challenging banks American Banker · 4d ago
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-13 | HAGGERTY KAITLIN | Officer | 1,426 | $262,125 | |
| 2026-05-12 | COOPER MATTHEW W. | General Counsel | 3,500 | $643,755 | |
| 2026-05-08 | KILLALEA PETER THOMAS | Director | 1,294 | · | |
| 2026-05-08 | WONG JENNIFER L | Director | 1,294 | · | |
| 2026-05-08 | SERRA EILEEN | Director | 1,294 | · | |
| 2026-05-08 | LEENAARS CORNELIS P. A. J. | Director | 1,294 | · | |
| 2026-05-08 | DETRICK CHRISTINE ROSE | Director | 1,294 | · | |
| 2026-05-08 | LOCOH DONOU FRANCOIS | Director | 1,294 | · | |
| 2026-05-08 | SHEPHERD MICHAEL | Director | 1,294 | · | |
| 2026-05-08 | HARFORD SUNI P. | Director | 1,294 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 9 Apr2026 | Josh Gottheimer | Democrat | sell | 15K–50K |
| 30 Jun2026 | Bill Keating | Democrat | buy | 1K–15K |
| 30 Jun2026 | Bill Keating | Democrat | buy | 1K–15K |
| 30 Jun2026 | Bill Keating | Democrat | buy | 1K–15K |
| 2026-04-13 | Ro Khanna | Democrat | Purchase | 15K–50K |
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $183.14 | -2.6% | $0.80 | $979 | -2.1% |
| 2 months | $192.18 | -7.1% | $0.80 | $933 | -6.7% |
| 3 months | $176.69 | +1.0% | $0.80 | $1,015 | +1.5% |
| 6 months | $237.36 | -24.8% | $1.60 | $759 | -24.1% |
| 1 year | $198.08 | -9.9% | $3.00 | $916 | -8.4% |
| 2 years | $136.94 | +30.3% | $5.40 | $1,343 | +34.3% |
| 3 years | $106.24 | +68.0% | $7.80 | $1,753 | +75.3% |
| 5 years | $146.54 | +21.8% | $13.20 | $1,308 | +30.8% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever COF does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.